Dec 20, 2017 – Announcement:
Crestone enters a Research Agreement with Colorado University at Boulder to develop efflux pump modulators for the treatment of Gram-negative infections, thus adding a fourth program to its pipeline.
Research Agreement with Colorado University at Boulder
Become a Part of Our Projects
Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investor, a team member, or a participant in our ongoing clinical studies.
Inquiries
Have a question or comment? Follow the link below to contact us about general inquiries.
Careers
Find work in a team-oriented environment at one of the leading Colorado pharma companies.
Clinical Studies
Learn how you can become part of our ongoing clinical study to fight deadly GI tract infections.